| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |